Proton-pump inhibitor exposure and prevalence of colorectal adenoma: a retrospective analysis from the Sakkopi study
In this large and well-characterised screening cohort, regular PPI therapy was not associated with colorectal adenoma prevalence, irrespective of dose or lesion characteristics.
Authors
- Bernhard Wernly (ORCID: https://orcid.org/0000-0003-4024-0220)
- E. Aigner
- Maria Flamm (ORCID: https://orcid.org/0000-0003-0816-6657)
- Laurenz Hauptmann (ORCID: https://orcid.org/0000-0003-2674-3796)
- Sarah Wernly (ORCID: https://orcid.org/0000-0001-9264-3115)
- Christian Datz (ORCID: https://orcid.org/0000-0001-7838-4532)
- Andreas Völkerer
- Georg Semmler (ORCID: https://orcid.org/0000-0002-0411-166X)
- Hannah Hofer
Institutions
- Paracelsus Medical University (AT)
- Krankenhaus Oberndorf (AT)
- Universitätskliniken Salzburg (AT)
- Arbeitsgemeinschaft für Klinische Ernährung (AT)
- Unfallkrankenhaus Salzburg (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1136/bmjgast-2025-002117
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00